Ireland· IE-PA-PA23355/041/001
Azecort 137 micrograms/50 micrograms per actuation nasal spray, suspension
A fluticason, kombinationen product containing azelastine hydrochloride + fluticasone propionate, registered in Ireland by Viatris Healthcare Limited. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Fluticason, kombinationen is registered in 11 of 19 countries.
Countries holding a registration under ATC R01AD58 (fluticason, kombinationen), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Fluticason, kombinationen · ATC R01AD58
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Azelastine hydrochloride + Fluticasone propionate
- Manufacturer
- Viatris Healthcare Limited
- Country
- Ireland (IE)
- ATC code
- R01AD58
- ATC class
- Fluticason, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA23355/041/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under R01AD58
Fluticason, kombinationen, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9442a150-2405-4391-afb8-c259936484f3 GET /v1/drugs/9442a150-2405-4391-afb8-c259936484f3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Nasal spray, suspension",
"routes": [
"Nasal use"
],
"source": "hpra",
"atc_all": [
"R01AD",
"R01AD58"
],
"strength": null,
"pa_number": "PA23355/041/001",
"substances": [
"Azelastine hydrochloride",
"Fluticasone propionate"
],
"legal_basis": "Fixed combination application (Article 10b of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "22/02/2013",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": "IC0166-204-070"
}See everything about fluticason, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.